The novel β2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells
Crossref DOI link: https://doi.org/10.1007/s00280-015-2801-0
Published Online: 2015-06-23
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kraus, Johannes
Kraus, Marianne
Liu, Nora
Besse, Lenka
Bader, Jürgen
Geurink, Paul P.
de Bruin, Gerjan
Kisselev, Alexei F.
Overkleeft, Herman
Driessen, Christoph
License valid from 2015-06-23